Filed: 2/14/2025ACC: 0000899140-25-000321
📋 What this filing means
SARISSA CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $322.86M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$322.86M
Total AUM (reported)
50.60M
Total Shares
Allocation by class
COM$198.98M61.6%
COM CL A$72.61M22.5%
COM NEW$39.22M12.1%
SPONS ADR NEW$12.05M3.7%
Portfolio Concentration
Top 3$241.06M74.7%
4–10$81.80M25.3%
Top 3 weight
74.7%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 50.60M
Sole
Full voting authority
50.60M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings8
Rows:
INNOVIVA INC
SOLEShares7.28M
TypeSH
Market value$126.26M
39.11%
Sole
7.28M
Shared
0.00
None
0.00
IRONWOOD PHARMACEUTICALS INC
SOLEShares16.39M
TypeSH
Market value$72.61M
22.49%
Sole
16.39M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares309.12K
TypeSH
Market value$42.19M
13.07%
Sole
309.12K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares833.80K
TypeSH
Market value$39.22M
12.15%
Sole
833.80K
Shared
0.00
None
0.00
GILEAD SCIENCES INC
SOLEShares262.08K
TypeSH
Market value$24.21M
7.50%
Sole
262.08K
Shared
0.00
None
0.00
AMARIN CORP PLC
SOLEShares24.85M
TypeSH
Market value$12.05M
3.73%
Sole
24.85M
Shared
0.00
None
0.00
LANTHEUS HLDGS INC
SOLEShares63K
TypeSH
Market value$5.64M
1.75%
Sole
63K
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares618K
TypeSH
Market value$686.0K
0.21%
Sole
618K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
INNOVIVA INCSOLE | COM | 7.28M | SH | $126.26M 39.11% | 7.28M | 0.00 | 0.00 |
IRONWOOD PHARMACEUTICALS INCSOLE | COM CL A | 16.39M | SH | $72.61M 22.49% | 16.39M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 309.12K | SH | $42.19M 13.07% | 309.12K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 833.80K | SH | $39.22M 12.15% | 833.80K | 0.00 | 0.00 |
GILEAD SCIENCES INCSOLE | COM | 262.08K | SH | $24.21M 7.50% | 262.08K | 0.00 | 0.00 |
AMARIN CORP PLCSOLE | SPONS ADR NEW | 24.85M | SH | $12.05M 3.73% | 24.85M | 0.00 | 0.00 |
LANTHEUS HLDGS INCSOLE | COM | 63K | SH | $5.64M 1.75% | 63K | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM | 618K | SH | $686.0K 0.21% | 618K | 0.00 | 0.00 |